Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

July 27, 2020

Linda Clark and Brad Gallagher Published on Pharmacy Insider Blog

Linda Clark, Health Care Controversies Team leader, and Brad Gallagher, counsel, recently had their “Caremark’s Bold Move to Restrict Dispensing and Access to Products on the Formulary” article published on the Pharmacy Insider blog.

“Suspect product” lists have been used for years by pharmacy benefit managers (PBMs) to target independent pharmacies and subject them to heightened scrutiny. These lists often target high margin products or other drugs that, for other unknown reasons, may be disfavored by PBMs without regard to formularies of individual plans. The lists are secret, and only “word-of-mouth” through the experiences of other network pharmacies do we learn of the targeted products or manufacturers.”

Read the full article here.

Featured Media

Alerts

Revised IRS Form 8038-CP

Alerts

The IRS Clarifies Standards for LLCs to Receive Determination Letter of 501(c)(3) Status

Alerts

NYS OPWDD Issues Vaccine Guidance to ICFs

Alerts

State and Federal Regulations Require NYS Health Care and Human Services Facilities to Implement Vaccine Mandates

Alerts

Tax-Exempt Bond Provisions Included in the Infrastructure Investment and Jobs Act

Alerts

Time to HIT back as PBMs Gain More Control of Sensitive Health Information Through Mergers

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out